Dr. Nikhil Narang is an advanced heart failure cardiologist with a speciality in cardiac transplant and durable mechanical circulatory suppor He provides comprehensive, personalized care for patients with complex heart conditions, including chronic or acute heart failure and cardiac amyloidosis.
Dr. Narang attended medical school at the University of Illinois-Chicago, and then proceeded to complete his training in internal medicine, cardiovascular disease and advanced heart failure at the University of Chicago. Dr. Narang is an Assistant Professor of Medicine and also serves as the Medical Director fo Mechanical Circulatory Support At Endeavor Health.
Dr. Narang is an active clinical investigator with research that spans the breadth of heart failure including heart transplantation, mechanical circulatory support, and cardiogenic shock. His has over 100 published manuscripts including articles that have been published in the Journal of the American Medical Association, Circulation, Journal of American College of Cardiology: Heart Failure, the Journal of Heart and Lung Transplantation, and Journal of Cardiac Failure.Dr. Nikhil Narang is an advanced heart failure cardiologist with a speciality in cardiac transplant and durable mechanical circulatory suppor He provides comprehensive, personalized care for patients with complex heart conditions, including chronic or acute heart failure and cardiac amyloidosis.
Waitlist Outcomes of Multiorgan Heart Transplant Candidates.
Waitlist Outcomes of Multiorgan Heart Transplant Candidates. J Heart Lung Transplant. 2026 Oct 27.
PMID: 42946272
Unintended shifts in high-priority adult heart transplant listings after the OPTN's September 2025 policy change.
Unintended shifts in high-priority adult heart transplant listings after the OPTN's September 2025 policy change. J Heart Lung Transplant. 2026 Oct 17.
PMID: 42892347
Development and Validation of an Adult Medical Urgency Score for US Donor Heart Allocation.
Development and Validation of an Adult Medical Urgency Score for US Donor Heart Allocation. JAMA. 2026 Oct 12.
PMID: 42862588
Evolving Evidence-Driven Strategies in Cardiogenic Shock Management.
Evolving Evidence-Driven Strategies in Cardiogenic Shock Management. JACC Adv. 2026 Oct; 5(10 Pt 2):103225.
PMID: 42743904
When the Gradient Falls, Do Symptoms Follow? Understanding the impact of Myosin Inhibitors on Patient Reported Outcomes.
When the Gradient Falls, Do Symptoms Follow? Understanding the impact of Myosin Inhibitors on Patient Reported Outcomes. J Card Fail. 2026 Sep 10.
PMID: 42722326
Disparities in Listing With a Durable Left Ventricular Assist Device After 2018 Heart Allocation Policy Change.
Disparities in Listing With a Durable Left Ventricular Assist Device After 2018 Heart Allocation Policy Change. JACC Heart Fail. 2026 Aug 03; 103241.
PMID: 42554539
Potential Impact of the OPTN Status Escalation Policy for Adult Heart Transplant Candidates With Durable LVADs.
Potential Impact of the OPTN Status Escalation Policy for Adult Heart Transplant Candidates With Durable LVADs. Circ Heart Fail. 2026 Jul; 19(7):e013854.
PMID: 42335275
High Rate of Transplantation Before Review of Status Exception Requests Among Adult Heart Transplant Candidates.
High Rate of Transplantation Before Review of Status Exception Requests Among Adult Heart Transplant Candidates. Circ Heart Fail. 2026 Jul; 19(7):e013994.
PMID: 42329622
Artifactual declines in durable LVAD utilization among heart transplant candidates: Selection bias in transplant registries.
Artifactual declines in durable LVAD utilization among heart transplant candidates: Selection bias in transplant registries. J Heart Lung Transplant. 2026 Nov; 45(11):1809-1817.
PMID: 42263896
Compensating Heart Failure Cardiologists: Is the RVU Model the Right Model?
Compensating Heart Failure Cardiologists: Is the RVU Model the Right Model? Circ Heart Fail. 2026 Jun; 19(6):e013838.
PMID: 41944038